The Regulation of INK4/ARF in Cancer and Aging

Cell

Volumn 127, Issue 2, 2006, Pages 265-275

  Kim, William Y ^a   Sharpless, Norman E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; BUSULFAN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLINE; PROTEIN P16INK4A; PROTEIN P18; PROTEIN P19; TUMOR SUPPRESSOR PROTEIN;

AGING; ASTROCYTOMA; BACTERIAL ARTIFICIAL CHROMOSOME; BLADDER CANCER; CARCINOGENESIS; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; EXON; GENE CONTROL; GENE DELETION; GENE FUNCTION; GENE LOCUS; GENOME; GENOTOXICITY; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; IONIZING RADIATION; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; MOUSE STRAIN; MYELODYSPLASIA; NONHUMAN; OPEN READING FRAME; OXIDATIVE STRESS; PANCREAS CARCINOMA; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SEQUENCE HOMOLOGY; TISSUE SPECIFICITY;

EID: 33750030758     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.10.003     Document Type: Review

References (83)

1. Allsopp R.C., Morin G.B., Horner J.W., DePinho R., Harley C.B., and Weissman I.L. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9 (2003) 369-371
2. Aslanian A., Iaquinta P.J., Verona R., and Lees J.A. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev. 18 (2004) 1413-1422
3. Bardeesy N., Aguirre A.J., Chu G.C., Cheng K.H., Lopez L.V., Hezel A.F., Feng B., Brennan C., Weissleder R., Mahmood U., et al. Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 103 (2006) 5947-5952
4. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., and Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature 395 (1998) 124-125
5. Ben-Saadon R., Fajerman I., Ziv T., Hellman U., Schwartz A.L., and Ciechanover A. The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue. J. Biol. Chem. 279 (2004) 41414-41421
6. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
7. Bruggeman S.W., Valk-Lingbeek M.E., van der Stoop P.P., Jacobs J.J., Kieboom K., Tanger E., Hulsman D., Leung C., Arsenijevic Y., Marino S., and van Lohuizen M. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 19 (2005) 1438-1443
8. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., and Fornace Jr. A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36 (2004) 343-350
9. Burri N., Shaw P., Bouzourene H., Sordat I., Sordat B., Gillet M., Schorderet D., Bosman F.T., and Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81 (2001) 217-229
10. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
11. Chen J.H., Stoeber K., Kingsbury S., Ozanne S.E., Williams G.H., and Hales C.N. Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J. Biol. Chem. 279 (2004) 49439-49446
12. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
13. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
14. Colombo E., Martinelli P., Zamponi R., Shing D.C., Bonetti P., Luzi L., Volorio S., Bernard L., Pruneri G., Alcalay M., and Pelicci P.G. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 66 (2006) 3044-3050
15. Dai C.Y., and Enders G.H. p16 INK4a can initiate an autonomous senescence program. Oncogene 19 (2000) 1613-1622
16. de Haan G., and Van Zant G. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 93 (1999) 3294-3301
17. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250
18. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61 (2001) 3225-3229
19. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352 (2005) 254-266
20. Forbes S., Clements J., Dawson E., Bamford S., Webb T., Dogan A., Flanagan A., Teague J., Wooster R., Futreal P.A., and Stratton M.R. Cosmic 2005. Br. J. Cancer 94 (2006) 318-322
21. Fox C.A., and McConnell K.H. Toward biochemical understanding of a transcriptionally silenced chromosomal domain in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 8629-8632
22. Gil J., Bernard D., Martinez D., and Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6 (2004) 67-72
23. Gonzalez S., Klatt P., Delgado S., Conde E., Lopez-Rios F., Sanchez-Cespedes M., Mendez J., Antequera F., and Serrano M. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 440 (2006) 702-706
24. Gray-Schopfer V.C., Cheong S.C., Chong H., Chow J., Moss T., Abdel-Malek Z.A., Marais R., Wynford-Thomas D., and Bennett D.C. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?. Br. J. Cancer 95 (2006) 496-505
25. Greenblatt M.S., Beaudet J.G., Gump J.R., Godin K.S., Trombley L., Koh J., and Bond J.P. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncogene 22 (2003) 1150-1163
26. Herbig U., Ferreira M., Condel L., Carey D., and Sedivy J.M. Cellular senescence in aging primates. Science 311 (2006) 1257
27. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004) 501-513
28. Herman J.G., Jen J., Merlo A., and Baylin S.B. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56 (1996) 722-727
29. Hewitt C., Lee Wu C., Evans G., Howell A., Elles R.G., Jordan R., Sloan P., Read A.P., and Thakker N. Germline mutation of ARF in a melanoma kindred. Hum. Mol. Genet. 11 (2002) 1273-1279
30. Huot T.J., Rowe J., Harland M., Drayton S., Brookes S., Gooptu C., Purkis P., Fried M., Bataille V., Hara E., et al. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22 (2002) 8135-8143
31. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
32. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., and Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12 (2006) 446-451
33. Iwasa H., Han J., and Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8 (2003) 131-144
34. Jacobs J.J., and de Lange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14 (2004) 2302-2308
35. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., and van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397 (1999) 164-168
36. Jacobs J.J., Keblusek P., Robanus-Maandag E., Kristel P., Lingbeek M., Nederlof P.M., van Welsem T., van de Vijver M.J., Koh E.Y., Daley G.Q., and van Lohuizen M. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat. Genet. 26 (2000) 291-299
37. Janzen V., Forkert R., Fleming H., Saito Y., Waring M., Dombkowski D., Cheng T., DePinho R., Sharpless N., and Scadden D. Stem cell aging modified by the cyclin dependent kinase inhibitor, p16INK4a. Nature 443 (2006) 421-426
38. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., and Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91 (1997) 649-659
39. Kawasaki H., and Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431 (2004) 211-217
40. Korgaonkar C., Zhao L., Modestou M., and Quelle D.E. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol. Cell. Biol. 22 (2002) 196-206
41. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., and Sharpless N.E. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004) 1299-1307
42. Krishnamurthy J., Ramsey M., Ligon K., Torrice C., Koh A., Bonner-Weir S., and Sharpless N. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 (2006) 453-457
43. Kuo M.L., den Besten W., Bertwistle D., Roussel M.F., and Sherr C.J. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 18 (2004) 1862-1874
44. Latres E., Malumbres M., Sotillo R., Martin J., Ortega S., Martin-Caballero J., Flores J.M., Cordon-Cardo C., and Barbacid M. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19 (2000) 3496-3506
45. Lindstrom M.S., and Zhang Y. B23 and ARF: friends or foes?. Cell Biochem. Biophys. 46 (2006) 79-90
46. Matheu A., Pantoja C., Efeyan A., Criado L.M., Martin-Caballero J., Flores J.M., Klatt P., and Serrano M. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18 (2004) 2736-2746
47. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., and Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99 (2006) 156-164
48. McDermott K.M., Zhang J., Holst C.R., Kozakiewicz B.K., Singla V., and Tlsty T.D. p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 4 (2006) e51 10.1371/journal.pbio.0040051
49. McKeller R.N., Fowler J.L., Cunningham J.J., Warner N., Smeyne R.J., Zindy F., and Skapek S.X. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc. Natl. Acad. Sci. USA 99 (2002) 3848-3853
50. Melk A., Kittikowit W., Sandhu I., Halloran K.M., Grimm P., Schmidt B.M., and Halloran P.F. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int. 63 (2003) 2134-2143
51. Melk A., Schmidt B.M., Takeuchi O., Sawitzki B., Rayner D.C., and Halloran P.F. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65 (2004) 510-520
52. Meng A., Wang Y., Van Zant G., and Zhou D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63 (2003) 5414-5419
53. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
54. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
55. Molofsky A.V., He S., Bydon M., Morrison S.J., and Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19 (2005) 1432-1437
56. Molofsky A.V., Slutsky S.G., Joseph N.M., He S., Pardal R., Krishnamurthy J., Sharpless N.E., and Morrison S.J. Increasing Ink4a expression reduces forebrain progenitor function and neurogenesis during aging. Nature 443 (2006) 448-452
57. Morris K.V., Chan S.W., Jacobsen S.E., and Looney D.J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305 (2004) 1289-1292
58. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., and Weissman I.L. The aging of hematopoietic stem cells. Nat. Med. 9 (1996) 1011-1016
59. Munro J., Stott F.J., Vousden K.H., Peters G., and Parkinson E.K. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res. 59 (1999) 2516-2521
60. Nairn R.S., Kazianis S., McEntire B.B., Della Coletta L., Walter R.B., and Morizot D.C. A CDKN2-like polymorphism in Xiphophorus LG V is associated with UV-B-induced melanoma formation in platyfish-swordtail hybrids. Proc. Natl. Acad. Sci. USA 93 (1996) 13042-13047
61. Nielsen G.P., Stemmer-Rachamimov A.O., Shaw J., Roy J.E., Koh J., and Louis D.N. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab. Invest. 79 (1999) 1137-1143
62. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., and Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409 (2001) 1067-1070
63. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
64. Pavey S., Conroy S., Russell T., and Gabrielli B. Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res. 59 (1999) 4185-4189
65. Piepkorn M. The expression of p16(INK4a), the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation. J. Am. Acad. Dermatol. 42 (2000) 741-745
66. Randerson-Moor J.A., Harland M., Williams S., Cuthbert-Heavens D., Sheridan E., Aveyard J., Sibley K., Whitaker L., Knowles M., Newton Bishop J., and Bishop D.T. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum. Mol. Genet. 10 (2001) 55-62
67. Reynisdottir I., Polyak K., Iavarone A., and Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9 (1995) 1831-1845
68. Rizos H., Puig S., Badenas C., Malvehy J., Darmanian A.P., Jimenez L., Mila M., and Kefford R.F. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 20 (2001) 5543-5547
69. Robles S.J., and Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16 (1998) 1113-1123
70. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., and Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14 (2000) 3037-3050
71. Satyanarayana A., Greenberg R.A., Schaetzlein S., Buer J., Masutomi K., Hahn W.C., Zimmermann S., Martens U., Manns M.P., and Rudolph K.L. Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol. Cell. Biol. 24 (2004) 5459-5474
72. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
73. Sharpless N.E. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat. Res. 576 (2005) 22-38
74. Sharpless N.E., Ramsey M.R., Balasubramanian P., Castrillon D.H., and DePinho R.A. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23 (2004) 379-385
75. Sherr C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60 (2000) 3689-3695
76. Sreeramaneni R., Chaudhry A., McMahon M., Sherr C.J., and Inoue K. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol. Cell. Biol. 25 (2005) 220-232
77. Stein G.H., Drullinger L.F., Soulard A., and Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19 (1999) 2109-2117
78. Stepanova L., and Sorrentino B.P. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood 106 (2005) 827-832
79. Stockl P., Hutter E., Zwerschke W., and Jansen-Durr P. Sustained inhibition of oxidative phosphorylation impairs cell proliferation and induces premature senescence in human fibroblasts. Exp. Gerontol. 41 (2006) 674-682
80. Uchida T., Kinoshita T., Nagai H., Nakahara Y., Saito H., Hotta T., and Murate T. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Blood 90 (1997) 1403-1409
81. Wang Y., Schulte B.A., Larue A.C., Ogawa M., and Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 107 (2006) 358-366
82. Weber J.D., Jeffers J.R., Rehg J.E., Randle D.H., Lozano G., Roussel M.F., Sherr C.J., and Zambetti G.P. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14 (2000) 2358-2365
83. Zindy F., Quelle D.E., Roussel M.F., and Sherr C.J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15 (1997) 203-211